ONC creates new CMO, consumer ehealth offices

Farzad Mostashari, MD - 32.42 Kb
Farzad Mostashari, MD
National Coordinator for Health IT Farzad Mostashari, MD, said his office (ONC) has created two new offices–the Office of the Chief Medical Officer (CMO) and the Office of Consumer eHealth.

Writing on the ONC's blog, HealthITBuzz, Mostashari said the primary function of the Office of the CMO will be "to infuse a clinical perspective across ONC on all activities which have clinical implications. Activities located in this office will include safety, useability, clinical decision support, meaningful use policy development and quality including metrics and measurement development."

The Office of Consumer eHealth will continue the work on consumer engagement begun in the ONC's Office of Policy and Planning, the blog said. "Creation of this new office provides exciting opportunities for ONC to expand upon the work that is currently underway, including the pledge program and patient-focused challenges. Creation of the Office of Consumer eHealth demonstrates ONC’s strong commitment to enabling patient and family engagement in healthcare," Mostashari wrote.

ONC will undertake a nationwide search for both a CMO and a director of the Office of Consumer eHealth. 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.